Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jerry Shapiro

Showing results (291-300 of 316) with videos related to

Pageof 32
Sort By:
Journal of Cosmetic Dermatology|April 18, 2020
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severityAndy Goren, Sergio Vaño-Galván, Carlos Gustavo Wambier, et al.
Frontiers in Medicine|August 5, 2021
Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled TrialJohn McCoy, Andy Goren, Flávio Adsuara Cadegiani, et al.
Journal of the American Academy of Dermatology|May 26, 2026
Impact of Phosphodiesterase-5 Inhibitor Treatment Delay on Secondary Raynaud's Phenomenon Outcomes: A Retrospective Cohort StudyIsabella Zappi, Derek Maas, Michelle Sikora, et al.
Immunotherapy|July 5, 2023
A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areataBrett King, Xingqi Zhang, Walter Gubelin Harcha, et al.
Lancet (London, England)|April 16, 2023
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trialBrett King, Xingqi Zhang, Walter Gubelin Harcha, et al.
The Journal of Dermatology|September 27, 2024
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalisNatasha Mesinkovska, Brett King, Xingqi Zhang, et al.
Journal of the American Academy of Dermatology|September 1, 2004
Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata FoundationElise A Olsen, Maria K Hordinsky, Vera H Price, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2025
Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopeciaAzael Freites-Martinez, Zoe Apalla, Jerry Shapiro, et al.
Journal of the American Academy of Dermatology|May 25, 2020
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign"Carlos Gustavo Wambier, Sergio Vaño-Galván, John McCoy, et al.
JAMA Network Open|January 6, 2026
Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast CancerDanbee Kang, Lukas Kraehenbuehl, Haseen Lee, et al.
Pageof 32

Showing results (291-300 of 316) with videos related to

Sort By:
Pageof 32
Journal of Cosmetic Dermatology|April 18, 2020
A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severityAndy Goren, Sergio Vaño-Galván, Carlos Gustavo Wambier, et al.
Frontiers in Medicine|August 5, 2021
Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled TrialJohn McCoy, Andy Goren, Flávio Adsuara Cadegiani, et al.
Journal of the American Academy of Dermatology|May 26, 2026
Impact of Phosphodiesterase-5 Inhibitor Treatment Delay on Secondary Raynaud's Phenomenon Outcomes: A Retrospective Cohort StudyIsabella Zappi, Derek Maas, Michelle Sikora, et al.
Immunotherapy|July 5, 2023
A plain language summary on ritlecitinib treatment for adults and adolescents with alopecia areataBrett King, Xingqi Zhang, Walter Gubelin Harcha, et al.
Lancet (London, England)|April 16, 2023
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trialBrett King, Xingqi Zhang, Walter Gubelin Harcha, et al.
The Journal of Dermatology|September 27, 2024
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalisNatasha Mesinkovska, Brett King, Xingqi Zhang, et al.
Journal of the American Academy of Dermatology|September 1, 2004
Alopecia areata investigational assessment guidelines--Part II. National Alopecia Areata FoundationElise A Olsen, Maria K Hordinsky, Vera H Price, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|September 9, 2025
Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopeciaAzael Freites-Martinez, Zoe Apalla, Jerry Shapiro, et al.
Journal of the American Academy of Dermatology|May 25, 2020
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The "Gabrin sign"Carlos Gustavo Wambier, Sergio Vaño-Galván, John McCoy, et al.
JAMA Network Open|January 6, 2026
Racial and Ethnic Disparities in Persistent Chemotherapy-Induced Alopecia Among Women With Breast CancerDanbee Kang, Lukas Kraehenbuehl, Haseen Lee, et al.
Pageof 32